SCHEMBL8091287

SCHEMBL8091287

CCC(NCc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.57
ATM Q13315 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
TDP1 Q9NUW8 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
AKT1 P31749 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRB2 P47870 1/20 0.44
METAP2 P50579 1/20 0.42
METAP1 P53582 1/20 0.42
ATP1A1 P05023 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190054 0.88 SMN1; SMN2 (0.61) L3MBTL1ATMSMN1; SMN2MEN1KMT2A
SCHEMBL9063682 0.88 SMN1; SMN2 (0.61) L3MBTL1ATMSMN1; SMN2MEN1KMT2A
SCHEMBL4345247 0.88 SMN1; SMN2 (0.61) L3MBTL1ATMSMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL3756451 0.86 SMN1; SMN2 (0.59) L3MBTL1ATMCYP1A2CYP2D6CYP2C19
SCHEMBL8092732 0.85 SMN1; SMN2 (0.63) L3MBTL1ATMCYP1A2CYP2D6CYP2C19
SCHEMBL11883479 0.84 SMN1; SMN2 (0.56) L3MBTL1ATMSMN1; SMN2MEN1KMT2A
SCHEMBL7176511 0.83 MEN1 (0.49) L3MBTL1CYP1A2CYP2D6CYP2C19SMN1; SMN2
SCHEMBL8092329 0.81 TDP1 (0.59) L3MBTL1TDP1SMN1; SMN2MEN1KMT2A
SCHEMBL4459857 0.81 ATM (0.55) L3MBTL1ATMCYP1A2CYP2D6CYP2C19
SCHEMBL28295645 0.81 ATM (0.58) L3MBTL1ATMCYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed
WO-1991009594-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1991-07-11 WO disclosed